RSS

long-acting antipsychotics (LATs)

Real world evidence from a study involving almost 30,000 people, supporting the benefits of long-acting antipsychotics (LATs) in reducing the risk of mortality among schizophrenic patients, has been announced by Janssen Pharmaceutical more

News